Leap Therapeutics, Inc. (LPTX)
| Market Cap | 268.38M |
| Revenue (ttm) | 1.50M |
| Net Income (ttm) | -32.43M |
| Shares Out | 76.39M |
| EPS (ttm) | -0.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 929,225 |
| Open | 2.95 |
| Previous Close | 2.99 |
| Day's Range | 2.91 - 3.05 |
| 52-Week Range | 1.33 - 4.17 |
| Beta | 0.48 |
| Analysts | Buy |
| Price Target | 4.80 (+61.6%) |
| Est. Earnings Date | Nov 11, 2021 |
About LPTX
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and ...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for LPTX stock is "Buy." The 12-month stock price forecast is 4.80, which is an increase of 61.62% from the latest price.
News
Best Short Squeeze Penny Stocks To Buy? 4 To Watch Right Now
Are these the top penny stocks to watch for a short squeeze? The post Best Short Squeeze Penny Stocks To Buy?
2 Penny Stocks That Could Soar Soon
These two tiny drugmakers might be hidden gems.
3 Biotech Stocks That Surged in September
Find out why last month was a big one for these three drugmakers.
Leap Therapeutics, AstraZeneca Shares Get Boost From Cancer Presentations
Leap Therapeutics Inc. ( LPTX , Financial) lived up to its name when it scored a big jump in stock price following its presentation at the recent European Society for Medical Oncology meeting. The Cambr...
Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of U...
CAMBRIDGE, Mass., Sept. 24, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closi...
Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants
CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the prici...
Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
CAMBRIDGE, Mass., Sept. 21, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it h...
Making Money With Penny Stocks During a Stock Market Crash
Trading penny stocks in a down market? Here's three tips and tricks to use in your search The post Making Money With Penny Stocks During a Stock Market Crash appeared first on Penny Stocks to Buy, Picks...
Hot Penny Stocks to Buy Right Now? 3 For Your Watchlist
Making a penny stocks watchlist in 2021? Here's three you should check out The post Hot Penny Stocks to Buy Right Now?
Why Leap Therapeutics Shares Are Trading Higher Today
Leap Therapeutics (NASDAQ:LPTX) shares are trading higher after the company announced it presented updated results for its DKN-01 plus tislelizumab which showed "compelling" activity in first-line patie...
Space Stocks: Why SPIR, ASTR, MNTS, RDW and SPCE Are Getting a Boost Today
Space stocks are taking off on Thursday and it's all thanks to Elon Musk's SpaceX reaching a major milestone for commercial space travel. The post Space Stocks: Why SPIR, ASTR, MNTS, RDW and SPCE Are Ge...
LPTX Stock: What Leap Therapeutics Investors Are Clicking Their Heels About Today
Leap Therapeutics (LPTX) stock is on the move today following an update from the biotechnology company for recent clinical trial results. The post LPTX Stock: What Leap Therapeutics Investors Are Clicki...
Leap Therapeutics Stock Is Moving Higher On Updated DKN-01 Combo Trial Data In Gastric Cancer
Leap Therapeutics Inc (NASDAQ: LPTX) announced updated data from the first-line cohort of the DisTinGuish Phase 2a trial evaluating DKN-01 combined with BeiGene Ltd's (NASDAQ: BGNE) tislelizumab and che...
Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO C...
CAMBRIDGE, Mass., Sept. 16, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pres...
3 Top Penny Stocks to Watch That Are Trending Right Now
Finding trending penny stocks can be a great strategy to use, here's three to watch The post 3 Top Penny Stocks to Watch That Are Trending Right Now appeared first on Penny Stocks to Buy, Picks, News an...
LPTX Stock: Why Leap Therapeutics Just Soared 30% to Start the Day
This company has announced that it will be presenting promising data and shares of LPTX stock have taken a leap. The post LPTX Stock: Why Leap Therapeutics Just Soared 30% to Start the Day appeared firs...
Why Are Leap Therapeutics Shares Trading Higher On Monday?
Leap Therapeutics Inc (NASDAQ: LPTX) stock increased over 30% premarket as the investors are responding positively ahead of the Company's presentation of new data from the first-line cohort of the DisTi...
Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress
CAMBRIDGE, Mass., Sept. 13, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Compa...
4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351%
These penny stocks have upcoming events you should know about. The post 4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351% appeared first on Penny Stocks to Buy, Picks, News and Information | P...
Leap Therapeutics to Participate at Two Upcoming Virtual Investor Conferences
CAMBRIDGE, Mass., Sept. 7, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...
Leap Therapeutics, Inc. (LPTX) Reports Q2 Loss
Leap Therapeutics, Inc. (LPTX) delivered earnings and revenue surprises of 7.69% and 0.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation
CAMBRIDGE, Mass., Aug. 13, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial ...
Analysts Estimate Leap Therapeutics, Inc. (LPTX) to Report a Decline in Earnings: What to Look Out for
Leap Therapeutics, Inc. (LPTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Leap Therapeutics to Present at the ESMO 2021 Virtual Congress
CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Compan...
Down 19.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Leap Therapeutics, Inc. (LPTX)
Leap Therapeutics, Inc. (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnin...